Publications by authors named "J A Garap"

Purpose: The prevalence of trachomatous inflammation-follicular (TF) in Papua New Guinea (PNG) suggests antibiotic mass drug administration (MDA) is needed to eliminate trachoma as a public health problem but the burden of trichiasis is low. As a result, WHO issued bespoke recommendations for the region. If ≥ 20% of 10-14-year-olds have both any conjunctival scarring (C1 or C2 or C3) and corneal pannus and/or Herbert's pits, MDA should be continued.

View Article and Find Full Text PDF

Purpose: Population-based prevalence surveys are essential for decision-making on interventions to achieve trachoma elimination as a public health problem. This paper outlines the methodologies of Tropical Data, which supports work to undertake those surveys.

Methods: Tropical Data is a consortium of partners that supports health ministries worldwide to conduct globally standardised prevalence surveys that conform to World Health Organization recommendations.

View Article and Find Full Text PDF

Background: In Melanesia, the prevalence of trachomatous inflammation-follicular (TF) suggests that public health-level interventions against active trachoma are needed. However, the prevalence of trachomatous trichiasis is below the threshold for elimination as a public health problem and evidence of conjunctival infection with trachoma's causative organism (Chlamydia trachomatis [CT]) is rare. Here, we examine the prevalence of ocular infection with CT and previous exposure to CT in three evaluation units (EUs) of Papua New Guinea.

View Article and Find Full Text PDF
Article Synopsis
  • - Trichiasis, where eyelashes touch the eye, can lead to blindness, making accurate prevalence data across affected regions essential for resource distribution.
  • - A study collected district-level data from 44 countries, refining estimates using the most reliable sources, standardizing for age and sex, and incorporating expert assessments when data was scarce.
  • - The 2016 global trichiasis estimate was 2.8 million cases, lower than earlier figures due to improved data quality, enhanced management services, and declines in active trachoma incidence.
View Article and Find Full Text PDF